American Renal Associates Holdings Balance Sheet - Quarterly (NYSE:ARA)

Add to My Stocks
$15.41 $0.05 (0.32%) ARA stock closing price Jul 13, 2018 (Closing)

The financial analysis of a company like American Renal Associates Holdings involves checking the three financial statements of the company in detail, of which the balance sheet is one. All three financial statements should be used to measure the financial performance of the company, and should form a part of the American Renal Associates Holdings stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. American Renal Associates Holdings had a long term debt of $512.82M at the end of 2018 Q1. To understand the debt servicing capacity of the company, one needs to look at American Renal Associates Holdings operating cash flow and American Renal Associates Holdings revenue also. American Renal Associates Holdings debt to equity ratio is 5.04.

View and download American Renal Associates Holdings quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Cash64.28M71.52M67.59M74.93M84M100.91M105.14M93.26M95.96M90.98M
Marketable Securities----------
Receivables93.55M86.4M89.3M88.09M86.91M86.29M81.9M77.04M78.49M79.6M
Inventory7.64M4.66M4.67M4.96M4.64M4.67M4.46M4.79M5.51M4.29M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets24.47M24.99M17.13M23.15M18.21M18.49M12.95M14.97M19.5M18.86M
Total Current Assets
189.96M187.59M178.7M191.13M193.77M210.38M204.47M190.08M199.47M193.74M
Property Plant & Equipment342.47M335.92M312.94M303.52M296.87M291.36M324.81M312.25M295.93M236.77M
Accumulated Depreciation173.79M167.39M146.05M138.03M129.54M121.24M159.68M151.36M144.73M94.07M
Net Property Plant & Equipment
168.68M168.53M166.89M165.49M167.33M170.11M165.13M160.88M151.2M142.7M
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges---------1.9M
Intangibles596.12M598.79M598.19M598.78M598.82M598.77M599.05M595.86M595.19M594.98M
Deposits & Other Assets15.01M9.28M8.63M8.88M7.47M6.75M6.59M6.17M6.57M6.14M
Total Assets
969.78M964.2M952.41M964.3M967.41M986.02M975.25M953.01M952.44M939.46M
Notes Payable----------
Accounts Payable40.88M33.42M33.86M28.18M24.6M31.12M23.27M23.51M23.85M22.57M
Current Portion Long-Term Debt45.12M44.53M44.18M45.71M45.55M48.27M43.58M40.57M27.17M25.61M
Current Portion Capital Leases----------
Accrued Expenses79.11M78.94M75.56M89.31M71.16M74.38M83.12M71.11M52.6M49.29M
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
165.12M156.9M153.61M163.21M141.33M153.79M149.98M135.2M103.63M97.47M
Mortgages----------
Deferred Taxes/Income9.56M8.99M1.11M1.12M1.52M1.27M6.72M7.16M15.09M15.02M
Convertible Debt----------
Long-Term Debt512.82M515.55M514.84M516.44M520.36M522.05M520.01M517.79M661.36M658.56M
Non-Current Capital Leases----------
Other Long-Term Liabilities22.81M22.38M27.61M29.45M29.5M32.87M26.93M38.16M9.92M9.48M
Total Liabilities
859.08M843.72M808.17M824.16M825.19M840.36M843.98M833.09M897.44M888.75M
Minority Interest148.76M139.89M110.98M113.92M132.46M130.36M140.33M134.76M107.41M108.21M
Preferred Stock----------
Common Stock Net----------
Capital Surplus68.63M67.85M94.15M95.36M93.59M95.06M69.76M72.4M--
Retained Earnings-124.48M-123.78M-124.02M-132M-129.89M-128.64M-121.52M-133.59M-124.5M-128.26M
Treasury Stock----------
Other Liabilities166.35M176.22M173.92M176.58M178.34M179.06M182.84M180.92M178.95M178.87M
Shareholders Equity110.69M120.48M144.24M140.13M142.22M145.66M131.26M119.91M55M50.71M
Total Liabilities & Shareholders Equity969.78M964.2M952.41M964.3M967.41M986.02M975.25M953.01M952.44M939.46M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Most investors just check the American Renal Associates Holdings stock price, and American Renal Associates Holdings historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the American Renal Associates Holdings PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: Anything that the American Renal Associates Holdings company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. American Renal Associates Holdings had total assets of $969.78M.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for American Renal Associates Holdings is $859.08M. Shareholders equity comes under liabilities as it is money the company owes the holders of ARA stock.

American Renal Associates Holdings Balance Sheet - Key Ratios

Current ratio
1.15
Debt to equity ratio
5.04
Asset turnover ratio
0.81
Receivables turnover
8.59
Price to book ratio
3.74

Quarterly Balance Sheets For American Renal Associates Holdings Inc Peers

AAC Holdings balance sheet, Addus HomeCare balance sheet, BioScrip balance sheet, HANGER INC balance sheet